These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22720771)

  • 1. ECDC public health response to the threat of resistant gonorrhoea in Europe.
    Van de Laar M
    Euro Surveill; 2012 Jun; 17(24):. PubMed ID: 22720771
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
    Unemo M; Golparian D; Potočnik M; Jeverica S
    Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group report on the diagnosis and treatment of gonorrhoea in Europe.
    Clarke E; Patel C; Patel R; Unemo M;
    Int J STD AIDS; 2020 Jan; 31(1):77-81. PubMed ID: 31793388
    [No Abstract]   [Full Text] [Related]  

  • 4. Gonococcal antimicrobial resistance: the implications for public health control.
    Ndowa FJ; Ison CA; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
    [No Abstract]   [Full Text] [Related]  

  • 5. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
    Tuddenham S; Ghanem KG
    Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonococcal antimicrobial resistance: challenges for public health control.
    Ndowa FJ; Ison CA; Cole MJ; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv3-4. PubMed ID: 24243877
    [No Abstract]   [Full Text] [Related]  

  • 7. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
    Unemo M; Golparian D; Hestner A
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

  • 10. Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.
    Chan CH; McCabe CJ; Fisman DN
    Sex Transm Infect; 2012 Apr; 88(3):200-4. PubMed ID: 22169277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The monitoring of Neisseria gonorrhoeae infection incidence and its resistance in Suceava County].
    Filipiuc S; Nicolae O; Luncă C; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1238-42. PubMed ID: 20191906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to the 2012 European gonorrhoea guideline in the WHO European Region according to the 2018-19 International Union against Sexually Transmitted Infections European Collaborative Clinical Group gonorrhoea survey.
    Unemo M; Clarke E; Boiko I; Patel C; Patel R;
    Int J STD AIDS; 2020 Jan; 31(1):69-76. PubMed ID: 31842695
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of multidrug-resistant Neisseria gonorrhoeae strains circulating worldwide.
    Tanaka M
    Int J Urol; 2012 Feb; 19(2):98-9. PubMed ID: 22168311
    [No Abstract]   [Full Text] [Related]  

  • 16. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.
    Martin IM; Hoffmann S; Ison CA;
    J Antimicrob Chemother; 2006 Sep; 58(3):587-93. PubMed ID: 16816397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
    Ndowa F; Lusti-Narasimhan M; Unemo M
    Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting core groups for gonorrhoea control: feasibility and impact.
    Giguère K; Alary M
    Sex Transm Infect; 2015 Jun; 91(4):241-4. PubMed ID: 25926404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial.
    Unemo M; Shipitsyna E; Domeika M;
    Sex Transm Infect; 2010 Nov; 86(6):442-4. PubMed ID: 20460266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.